NeuroPace (NPCE) Current Assets (2020 - 2026)
NeuroPace's (NPCE) quarterly Current Assets came in at $87.0 million in Q1 2026, down 10.77% year-on-year from $97.5 million in Q1 2025, and down 7.54% quarter-over-quarter from $94.1 million in Q4 2025.
NeuroPace (NPCE) Current Assets (2020 - 2026) Analysis & Trends
NeuroPace's Current Assets history runs 7 years deep, the most recent figure standing at $87.0 million for Q1 2026.
- On a quarterly basis, Current Assets fell 10.77% year-over-year to $87.0 million in Q1 2026; TTM through Mar 2026 was $87.0 million, a 10.77% decrease from a year earlier, with the FY2025 full-year figure at $94.1 million, up 15.66% from the prior year.
- Current Assets fell to $87.0 million in Q1 2026 per NPCE's latest filing, from $94.1 million in the prior quarter.
- Across five years, Current Assets topped out at $122.4 million in Q1 2022 and bottomed at $80.2 million in Q2 2024.
- The 5-year median for Current Assets is $92.7 million (2023), against an average of $93.3 million.
- Biggest YoY gain for Current Assets was 159.98% in 2022; the steepest drop was 26.43% in 2022.
- Year by year, Current Assets stood at $97.7 million in 2022, then retreated by 5.11% to $92.7 million in 2023, then declined by 12.27% to $81.3 million in 2024, then rose by 15.66% to $94.1 million in 2025, then retreated by 7.54% to $87.0 million in 2026.
- Per Business Quant, the three latest NPCE Current Assets figures stand at $87.0 million (Q1 2026), $94.1 million (Q4 2025), and $95.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 4.33 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 10.43 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 4.10 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 11.45 Bn |
| 10 | NeuroPace | 517.05 Mn | 463.07 Mn | 18.05 Mn | 86.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86.98 Mn |
| Dec 31, 2025 | 94.07 Mn |
| Sep 30, 2025 | 95.33 Mn |
| Jun 30, 2025 | 93.74 Mn |
| Mar 31, 2025 | 97.48 Mn |
| Dec 31, 2024 | 81.34 Mn |
| Sep 30, 2024 | 82.59 Mn |
| Jun 30, 2024 | 80.23 Mn |
| Mar 31, 2024 | 84.25 Mn |
| Dec 31, 2023 | 92.72 Mn |
| Sep 30, 2023 | 83.97 Mn |
| Jun 30, 2023 | 86.51 Mn |
| Mar 31, 2023 | 90.16 Mn |
| Dec 31, 2022 | 97.71 Mn |
| Sep 30, 2022 | 104.37 Mn |
| Jun 30, 2022 | 112.46 Mn |
| Mar 31, 2022 | 122.42 Mn |
| Dec 31, 2021 | 132.82 Mn |
| Sep 30, 2021 | 140.49 Mn |
| Jun 30, 2021 | 146.40 Mn |